Antibiotic for bacteria to find a new molecule and “determined candidate” Liodicin

A group of researchers at the University of McMaster in Canada, have identified a molecule they described “Candidate Signs” To become a new class Antibiotic: This is Lorioosidin. According to the researchers, this molecular bacteria can be used in the other way from other antibiotics, which can be used as “challenging the drug even to some people who are very resistant to bacteria.” Scientists have explained the results of their research in an article by Nature, a scientific magazine, and other research groups from various countries participated.

This invention responds to the important requirement of new antimicrobial drugs because bacteria and other microorganisms create new ways to combat existing drugs. This opposition is explained by a statement of McMaster University, One of the main threats to public health On the planet, according to the World Health Organization.

“Our older drugs are less and less effective because bacteria are resistant to them,” says Jerry Wright, who directed the team. About 4.5 million people die each year due to antibiotic -recessed infections, and he emphasizes anything other than the worsening of the situation. Wright and his group found it The new molecule is “very promising” As the first pharmacological clue it attacks bacteria in a different way from other antibiotics.

Faith in scientists, their resistance characteristics

Made by a type of bacteria called lorosidine Panipasilus, which is obtained by researchers A mud sample Collection in Hamilton’s backyard (city where the university is located). It combines directly with a bacterial protein set of machines, which prevents the ability to grow and survive. “This is a new molecule with a new activity,” says Right summarized.

Researchers have noticed how one year grew in the bacterial laboratory of the soil model, until they notice that one of those bacteria (panicasles) is produced A new highly active substance against other bacteriaIn addition to people who are usually resistant to antibiotics.

Scientists are confident that the properties of lorosidine meet many needs: It is not toxic to human cellsIt does not undergo the current mechanisms of resistance to antibiotics and works well in the animal infection model.